Abstract
In the present study, we evaluated the metabolicO-methylation of several catechol-containing tea polyphenols by human placental catechol-O-methyltransferase (COMT). (−)-Epicatechin, (+)-epicatechin, and (−)-epigallocatechin were good substrates for metabolic O-methylation by placental cytosolic COMT (150–500 pmol/mg of protein/min), but (−)-epicatechin gallate and (−)-epigallocatechin gallate were O-methylated at much lower rates (<50 pmol/mg of protein/min). When (−)-epicatechin was used as substrate, its O-methylation by human placental COMT showed dependence on incubation time, cytosolic protein concentration, incubation pH, and concentration ofS-adenosyl-l-methionine (the methyl donor). Analysis of cytosolic COMT from six human term placentas showed that the O-methylation of increasing concentrations of (−)-epicatechin or (−)-epigallocatechin follows typical Michaelis-Menten kinetics, with Km andVmax values of 2.2 to 8.2 μM and 132 to 495 pmol/mg of protein/min for (−)-epicatechin and 3.9 to 6.7 μM and 152 to 310 pmol/mg of protein/min for (−)-epigallocatechin, respectively. Additional analysis revealed that COMT-catalyzedO-methylation of (−)-epicatechin and (−)-epigallocatechin was strongly inhibited in a concentration-dependent manner byS-adenosyl-l-homocysteine (IC50 = 3.2–5.7 μM), a demethylated product ofS-adenosyl-l-methionine. This inhibition byS-adenosyl-l-homocysteine follows a mixed (competitive plus noncompetitive) mechanism of enzyme inhibition. In summary, several catechol-containing tea polyphenols are rapidlyO-methylated by human placental cytosolic COMT. This metabolic O-methylation is subject to strong inhibitory regulation by S-adenosyl-l-homocysteine, which is formed in large quantities during theO-methylation of tea polyphenols.
Footnotes
-
Send reprint requests to: Dr. Bao Ting Zhu, Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina, 700 Sumter Street, Columbia, SC 29208. E-mail:btzhu{at}pharm.sc.edu
-
↵1 William and Myrle M. Garbe Professor of Cancer and Leukemia Research.
-
This study was supported by National Institutes of Health Grants CA 74787, CA 49756, and ES 05022.
- Abbreviation used is::
- COMT
- catechol-O-methyltransferase
- Received January 11, 2000.
- Accepted May 31, 2000.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|